Loading Events

« All Events

  • This event has passed.

Claudio Soares

2024-01-25 @ 12:00 - 13:00 EST

We are pleased to invite you to a Special Seminar hosted by the Douglas on January 25, 2024.

Join us online from 12 :00 – 13 :00 for a talk and Q&A with Dr. Claudio Soares.




Claudio N. Soares MD, PhD, FRCPC, MBA
Professor, Department of Psychiatry, Queen’s University School of Medicine, Kingston Ontario
Regional Clinical Lead, Mental Health & Addictions, Ontario Health East


The Evolving Landscape of Depression Clinical Trials: Lessons Learned, Time for Change


  • To appreciate the evolution of clinical trial research in Canada, with a particular focus on depression
  • To acknowledge the limitations and challenges of existing clinical trial frameworks
  • To learn about emerging, transformative approaches to clinical trials in depression


Dr. Soares is a Professor and former Chair of the Department of Psychiatry at Queen’s University School of Medicine in Kingston, Ontario – Canada. He also serves as Chair of the Psychedelic Science Advisory Committee for Queen’s University. Other current leadership roles include Executive Lead for the Canadian Biomarker Integration Network in Depression (CAN- BIND) and Regional Lead for Mental Health and Addictions, Ontario Health East.

Dr. Soares trained as a psychiatrist at the University of Sao Paulo, Brazil, where he also completed his Ph.D. work on estrogen effects for the management of depression in midlife women. He further pursued a postdoctoral fellowship in Perinatal and Reproductive Psychiatry at the Massachusetts General Hospital, Harvard Medical School, where he later served as an Assistant Professor of Psychiatry before relocating to Canada in 2004.

His research has focused on the design and implementation of clinical trials in depression, with a primary focus on novel hormonal and non-hormonal options for midlife women experiencing mood and anxiety disorders, vasomotor symptoms, and sleep problems. His pioneering work on the use of estradiol for menopause-related depression led to the inclusion of this agent as part of the treatment recommendations by CANMAT guidelines. His most recent research has focused on the use of digital health technologies for treatment monitoring and relapse prevention in depression, and the role of psychedelics for the management of psychiatric disorders.

Dr. Soares is a sought-after educator with more than 220 presentations at national and international meetings. He has written extensively in the areas of mood disorders and women’s mental health, with more than 200 publications including articles in the Archives of General Psychiatry (JAMA Psychiatry), Menopause, Obstetrics and Gynecology, Journal of Clinical Psychiatry, American Journal of Psychiatry, to name a few. He is currently the President-elect of the Menopause Society, in the USA.

He has received numerous grants and awards, including 3 NARSAD Awards from the Brain and Behavior Research Foundation (formerly NARSAD Foundation). His body of work has more than 12,000 citations to date.

How to participate

This seminar will be  virtual only.


12:00 - 13:00 EST
Event Category:
Event Tags: